Are you a proven leader with experience in strategic thinking and theoretical development, understand scientific concepts and have international experience? UMC is looking for a new CEO to lead an organization of 150 people in Uppsala, Sweden, devoted to supporting and enhancing global pharmacovigilance and patient safety.
In the role as CEO, you will handle important tasks every day that will influence people both inside and outside the organization, knowing that you contribute to the global effort to prevent patients suffering harm from their medicines. The role involves working on the global market and you will develop contacts around the world.
What you will do
All this in close collaboration with colleagues in Geneva and other global partners.
Highly desirable qualities
We are looking for a candidate with the following characteristics:
This recruitment is handled by Michaël Berglund.
Real-world impact – Working for the greater good
Learning organisation – Skilled and curious staff
Flexible work hours – Allows us to be at our best
Uppsala Monitoring Centre (UMC) is a centre for international service and scientific research in the field of pharmacovigilance. We are the WHO Collaborating Centre for International Drug Monitoring, and manage the technical and operational aspects of the WHO Programme for International Drug Monitoring since 1978.
As an independent, non-profit foundation, we support the World Health Organization, regulatory authorities, and other stakeholders who share our vision of advancing medicines safety. Through research and development of new scientific methods, we explore the benefits and harms of medicines for patients, and offer products and services used by health authorities and the pharmaceutical industry worldwide.
UMC follows the collective agreements between the Swedish Agency for Government Employers and Saco-S and ST. Union representatives are Malin Zaar (Saco-S) and Jessica Avasol (ST), +46 (0)18-65 60 60.